Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.
$7.15+11.02%
报价 2026-11-06
市值
$322.9M
EV
$294.5M
PE (TTM)
9.7x
预期 PE (FY2026)
26.7x
52 周区间距高点 -28.0%
$2.77$9.93
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-07不在筛选范围：industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| AGENAgenus Inc. | $322.9M | +11.0% | +26.2% | 76.5% | 9.7x | 3.4x | – | |
| IRDOpus Genetics, Inc. | $347.8M | +4.4% | -1.5% | 99.9% | – | – | – | |
| TTRXTurn Therapeutics Inc. | $287.9M | +6.0% | – | 0% | – | – | – | |
| FATEFate Therapeutics, Inc. | $213.9M | -0.8% | -10.6% | -343% | – | – | – | |
| ZNTLZentalis Pharmaceuticals, Inc. | $122.4M | +0.6% | -22.2% | 0% | – | – | – | |
| HURATuHURA Biosciences, Inc. | $103.9M | +1.2% | +50.0% | 0% | – | – | – | |
| SEERSeer, Inc. | $90.3M | -4.1% | -4.1% | 47% | – | – | – | |
| INOInovio Pharmaceuticals, Inc. | $83.9M | -16.2% | +10800.0% | 0% | – | – | – | |
| PLRXPliant Therapeutics, Inc. | $50.1M | -0.7% | -24.2% | 0% | – | – | – | |
| 同行中位数 | – | – | -4.1% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。